Attitudes and Believes About Vaccinations in a Supportive Care Patient Population

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

104 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-03-10

Study Completion Date

2024-07-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To learn about the attitudes and beliefs towards vaccination both before and after the COVID-19 pandemic in patients who have received supportive care.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Positive Activities for Asian American Cancer Patients and Caregivers

NCT05203614

Cancer

COMPLETED NA

Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced Cancer

NCT05058339

Advanced Malignant Solid Neoplasm COVID-19 Infection Hematopoietic and Lymphoid Cell Neoplasm +4 more

COMPLETED

Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer

NCT05904782

Cancer

RECRUITING

Supportive Care Service Availability for Cancer Caregivers in Community Oncology Practices

NCT03746314

Supportive Care

COMPLETED

Questionnaires in Assessing Attitudes About Legalization of Marijuana Use in Participants With Cancer

NCT03360799

Malignant Neoplasm

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary Objective:

Our primary objective is to assess patient perception of efficacy and safety of vaccinations.

Secondary Objectives:

To assess demographic predictors of those who would be considered as vaccine hesitant.

To assess patient preferred source of recommendations for or against vaccination.

To assess the role past side effects or allergic reactions play on patient perception of future vaccines.

To assess patient perception of vaccination prior to COVID-19.

To assess patient willingness to get the COVID-19 vaccine.

To assess patient willingness to get the influenza vaccine.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vaccinations

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Supportive care patient population

Attitudes and Believes About Vaccinations, questionnaires

patient population

Intervention Type OTHER

questionnaires, standard of care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

patient population

questionnaires, standard of care

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients who are seen as part of a clinic visit with the Supportive Care Clinic at M.D.

Anderson Cancer Center, also patients who are being seen by the inpatient Supportive Medicine Consultation Service.
2. Patients who are 18 years of age or older
3. Patients who are able to speak English.

Exclusion Criteria

1. Patients who are unable to sign written consent
2. Patients who are considered delirious at the time of the clinic encounter as defined by a Memorial Delirium Assessment Scale score of 7 or greater. The nursing staff, as a part of the patient intake process and routine care, performs the delirium assessment for clinic patients.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No